We are live on ! Find out more
LLY icon

Eli Lilly

1,147 hedge funds and large institutions have $70.3B invested in Eli Lilly in 2015 Q3 according to their latest regulatory filings, with 87 funds opening new positions, 373 increasing their positions, 474 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more call options, than puts

Call options by funds: $925M | Put options by funds: $601M

34% more first-time investments, than exits

New positions opened: 87 | Existing positions closed: 65

17% more funds holding in top 10

Funds holding in top 10: 4856 (+8)

1% more funds holding

Funds holding: 1,1381,147 (+9)

0.21% less ownership

Funds ownership: 76.15%75.94% (-0.21%)

0% less capital invested

Capital invested by funds: $70.4B → $70.3B (-$161M)

21% less repeat investments, than reductions

Existing positions increased: 373 | Existing positions reduced: 474

Holders
1,147
Holders Change
+9
Holders Change %
+0.79%
% of All Funds
32.02%
Holding in Top 10
56
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+16.67%
% of All Funds
1.56%
New
87
Increased
373
Reduced
474
Closed
65
Calls
$925M
Puts
$601M
Net Calls
+$324M
Net Calls Change
-$22.5M
Name Holding Trade Value Shares
Change
Change in
Stake
SC
76
Saturna Capital
Washington
$107M
O
77
OrbiMed
New York
$106M +$107M +1,272,000 New
State Board of Administration of Florida Retirement System
78
State Board of Administration of Florida Retirement System
Florida
$106M -$944K -11,187 -0.9%
SCCM
79
Schafer Cullen Capital Management
New York
$105M -$5.33M -63,083 -5%
PAMU
80
Pictet Asset Management (UK)
United Kingdom
$105M -$2.59M -30,669 -2%
CCI
81
Columbus Circle Investors
$104M +$83.1M +984,047 +374%
Fisher Asset Management
82
Fisher Asset Management
Washington
$104M +$17.8M +210,378 +20%
BJ
83
BlackRock Japan
Japan
$104M +$5.4M +64,008 +5%
RFC
84
Russell Frank Company
Washington
$102M +$17.5M +207,492 +20%
CNB
85
City National Bank
California
$97.9M +$3.8M +45,051 +4%
FAM
86
Fred Alger Management
New York
$94.7M +$89.3M +1,058,315 +1,456%
Citigroup
87
Citigroup
New York
$94.2M -$3.09M -36,610 -3%
PHS
88
PFM Health Sciences
California
$92.6M +$93.4M +1,106,139 New
Loomis, Sayles & Company
89
Loomis, Sayles & Company
Massachusetts
$91.1M +$12.3M +145,543 +15%
Schroder Investment Management Group
90
Schroder Investment Management Group
United Kingdom
$90.7M -$48.5M -574,566 -35%
HSBC Holdings
91
HSBC Holdings
United Kingdom
$90.1M +$25.3M +299,198 +38%
Jennison Associates
92
Jennison Associates
New York
$89.3M +$1.23M +14,615 +1%
Ameriprise
93
Ameriprise
Minnesota
$86.5M -$13.2M -156,597 -13%
MCM
94
Marsico Capital Management
Colorado
$85.6M +$63.6M +753,786 +280%
IG
95
ING Group
Netherlands
$85M -$8.97M -106,192 -9%
HM
96
HealthCor Management
New York
$83.7M +$84.4M +1,000,000 New
Canada Pension Plan Investment Board
97
Canada Pension Plan Investment Board
Ontario, Canada
$81.7M +$35.7M +423,348 +77%
AI
98
Analytic Investors
California
$79.9M -$36.7M -434,305 -31%
Robeco Institutional Asset Management
99
Robeco Institutional Asset Management
Netherlands
$78.9M +$324K +3,835 +0.4%
Nordea Investment Management
100
Nordea Investment Management
Sweden
$77.6M +$1.45M +17,133 +2%

LLY Hedge Fund Activity: Q3 2015 in Review

1,147 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q3 2015, worth a combined $70.3B — down 0.23% from $70.4B a quarter earlier.

Buyers outnumbered sellers: 87 funds opened new LLY positions and 65 closed out — a net gain of 22 holders — while 373 added to existing stakes and 474 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $776M. The largest seller was Wellington Management Group, cutting an estimated $713M.

  • 1,147 institutional investors held Eli Lilly (LLY) as of Q3 2015, up from 1,138 in Q2 2015.
  • Funds reported $70.3B of Eli Lilly stock for Q3 2015, down 0.23% quarter-over-quarter.
  • 87 funds opened new Eli Lilly positions in Q3 2015 and 65 closed out, a net change of +22 holders.
  • The largest Eli Lilly buyer in Q3 2015 was JP Morgan Chase, an estimated $776M added.
  • The largest Eli Lilly seller in Q3 2015 was Wellington Management Group, an estimated $713M sold.

Based on aggregated 13F filings for Q3 2015.